Meeting News
March 17, 2020
Weekly treatment with isoniazid 900 mg and rifapentine 900 mg for 12 weeks resulted in higher treatment completion rates among patients with HIV in…
Meeting News
March 16, 2020
Study findings presented at CROI showed that a United States-funded program designed to reduce the risk for HIV infection in adolescent girls and…
Meeting News
March 16, 2020
An increase in January 2019 in HIV diagnoses among people who inject drugs, or PWID, in Cabell County, West Virginia — the largest relative…
Meeting News
March 14, 2020
Pregnancy does not increase the rate of rifapentine clearance, indicating that there is no need for a dose adjustment of the 3-month tuberculosis…
Meeting News
March 13, 2020
During a trial conducted in six clinics in Lusaka, Zambia, infants randomly assigned to receive point-of-care early infant HIV diagnosis all received…
Meeting News
March 13, 2020
Transgender women have modified profiles of biomarkers that correlate with with systemic inflammation and cardiovascular disease that are seemingly…
Meeting News
March 12, 2020
Dolutegravir and emtricitabine/tenofovir alafenamide fumarate (DTG+FTC/TAF) may be the safest and most effective HIV treatment regimen for pregnant…
Meeting NewsPerspective
March 12, 2020
The rate of HIV is decreasing quickly among women and men in Rakai, Uganda, due in part to the scale-up of voluntary medical male circumcision, or…
Meeting News
March 11, 2020
Low-dose pomalidomide was well-tolerated and helped clear high-grade squamous intraepithelial lesions caused by HPV in patients with and without HIV…
Meeting News
March 11, 2020
Universal test and treat strategies implemented in communities in Uganda and Kenya more than halved HIV infection and mortality rates among infants…